Eminent luminaries like Ajay Relan, Prakash Diwan, Lashit Sanghavi, Nikhil Vora etc had backed a stock touted to be the “next Page Industries”. Unfortunately, the promoter has gone missing and investors are now in the lurch
Subscribe to Blog via Email
Join 509 other subscribers
- Sunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 CrSunil Singhania's Abakkus has bought 10.69L shares of Aarti Pharma at ₹575 for ₹61.5 Cr. M-Cap is ₹5800 Cr. Promoters hold 46%. Co operates in 3 areas i.e. Xanthine derivatives, API & CDMO/CMO. It is largest Indian manufacturer of Xanthines & has Global market share of 15-20% ... Sunil Singhania's Abakkus has bought 10.69L shares […]
- PNB Housing is undergoing a transformation to morph into a franchise that will be strongerPNB Housing is undergoing a transformation to morph into a franchise that will be stronger, more resilient & with high predictability in earnings trajectory. Risk-reward profile is favorable for a long-term investor. Buy for TP of ₹1160 (38% upside) Download research... PNB Housing is undergoing a transformation to morph into a franchise that will be […]
- Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 (27% upside)Piramal Pharma is seeing strong momentum in CDMO. Postponement of the Biosecure Act is unlikely to cause growth related issues as China rebalancing drive by global innovators likely to continue. Other growth levers are intact. Buy for TP ₹320 (27% upside) Download report... Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 […]
Recent Posts
- PNB Housing is a strengthening franchise where the risk-reward profile is favorable for a long-term investor. Buy for target price of ₹1160 (38% upside): Motilal Oswal
- Piramal Pharma is seeing strong momentum in CDMO. Buy for target price f ₹320 (27% upside): ICICI Direct
- Hiren Ved has no Banking stocks in his portfolio. Ravi Dharamshi is very bullish about energy transition
- Protean eGov Technologies is a unique play on digital public infrastructure. Buy for target price of ₹2510 (24% upside): ICICI Direct
- Saurabh Mukherjea’s Marcellus PMS Fund has added new stocks to the Kings of Capital, Rising Giants & Little Champs portfolios and exited Eureka Forbes
Recent Comments